These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25301529)

  • 1. Impact of intravenous nitroglycerin in the management of acute decompensated heart failure.
    den Uil CA; Brugts JJ
    Curr Heart Fail Rep; 2015 Feb; 12(1):87-93. PubMed ID: 25301529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations.
    Elkayam U; Bitar F; Akhter MW; Khan S; Patrus S; Derakhshani M
    J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):227-41. PubMed ID: 15678242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
    Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
    JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure.
    den Uil CA; Caliskan K; Lagrand WK; van der Ent M; Jewbali LS; van Kuijk JP; Spronk PE; Simoons ML
    Intensive Care Med; 2009 Nov; 35(11):1893-9. PubMed ID: 19639300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.
    Elkayam U; Akhter MW; Singh H; Khan S; Usman A
    Am J Cardiol; 2004 Jan; 93(2):237-40. PubMed ID: 14715359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
    Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy.
    Dakak N; Makhoul N; Merdler A; Yechiely H; Kahana L; Halon DA; Schneeweiss A; Lewis BS
    Eur Heart J; 1993 Jun; 14(6):836-44. PubMed ID: 8325314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis.
    Levy P; Compton S; Welch R; Delgado G; Jennett A; Penugonda N; Dunne R; Zalenski R
    Ann Emerg Med; 2007 Aug; 50(2):144-52. PubMed ID: 17509731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure.
    den Uil CA; Lagrand WK; Spronk PE; van der Ent M; Jewbali LS; Brugts JJ; Ince C; Simoons ML
    Eur J Heart Fail; 2009 Apr; 11(4):386-90. PubMed ID: 19211570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic action of captopril in coronary patients with heart failure tolerant to nitroglycerin.
    Störk T; Eichstädt H; Möckel M; Gareis R; Bodemann T; Müller R
    Clin Cardiol; 1997 Dec; 20(12):999-1004. PubMed ID: 9422837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Organic nitrates: still interesting after all these years].
    Lisi M; Parker JD; Gori T
    Recenti Prog Med; 2009 Mar; 100(3):140-3. PubMed ID: 19475842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of high-dose intravenous nitrates in hypertensive acute heart failure.
    Wang K; Samai K
    Am J Emerg Med; 2020 Jan; 38(1):132-137. PubMed ID: 31327485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
    Loh E; Elkayam U; Cody R; Bristow M; Jaski B; Colucci WS
    J Card Fail; 2001 Jun; 7(2):114-21. PubMed ID: 11420762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
    Larsen AI; Gøransson L; Aarsland T; Tamby JF; Dickstein K
    Am Heart J; 1997 Sep; 134(3):435-41. PubMed ID: 9327699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilators in acute heart failure.
    Hollenberg SM
    Heart Fail Rev; 2007 Jun; 12(2):143-7. PubMed ID: 17447137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin].
    Kosminskiĭ PG; Vaniev SB; Vasechkin SS; Lazarev IA; Gruzdev AK; Magnitskiĭ AV; Sidorenko BA
    Kardiologiia; 1992 Sep; 32(9-10):15-8. PubMed ID: 1287301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.